SCOS 2022 Annual Conference 

August 5-6, 2022
Wild Dunes Resort | Isle of Palms, SC

     

Agenda

 

Friday, August 5, 2022*

12:00 PM
Registration Open/Networking Lunch/Resource Center  

1:00 PM
Welcome & Introductions
Gene Saylors, MD
President, South Carolina Oncology Society  

1:05 PM
Breaking Updates: No One Left Alone/Enhancing Oncology Model
Kashyap Patel, MD
Carolina Blood & Cancer Care Associates

1:35 PM
Integrative Oncology
Donald Abrams, MD
University of California San Francisco  

2:20 PM
Oral Vitamins and Nutraceuticals in Oncology: Facts over Fallacy
Laura Kerns, MPH, RD, CSO, LDN, FAND
The Gayle and Tom Benson Cancer Center, Ochsner Medical Center  

3:00 PM
Networking Break/Resource Center  

3:30 PM
Policy Updates and SCOS Priorities Moving Forward
Holly G. Pisarik, Pisarik Law Firm
Darra Coleman, Nexsen Pruet, LLC  

4:15 PM
How to Improve the Oncology Patient Care Experience
Susan Baker, MHA 
Author, Split Second Kindness  

5:00 PM
Networking Reception/Resource Center  

*CME/CNE credit not provided for August 5, 2022 


Saturday, February 12 

7:00 AM
Registration Open/Networking Breakfast/Resource Center  

8:00 AM
Welcome & Introductions
Gene Saylors, MD
President, South Carolina Oncology Society  

8:05 AM
Updates in Diffuse Large B-Cell Lymphoma
Brian Hess, MD
Medical University of South Carolina  

8:35 AM
CLL and Frontline Therapies
James Davis, PharmD, BCOP, Medical University of South Carolina  

9:05 AM
Enhancing Equity in Clinical Research: 
Lessons from Community Oncology Engagement Efforts
Richard Martin III, MD, MPH, Tennessee Oncology  

9:50 AM Networking Break/Resource Center  

10:15 AM
The Rise and Rise of Cellular Immunotherapy for Multiple Myeloma: ASH & ASCO Updates
Hamza Hashmi, MD, Medical University of South Carolina  

11:00 AM
Breast Cancer Updates
Antoinette Tan, MD, MHS, Atrium Health, Levine Cancer Institute  

11:45 AM Networking Lunch/Resource Center  

12:45 PM
Combining Immunotherapy and Radiation Therapy
Nitin Ohri, MD, MS, Albert Einstein College of Medicine   

1:30 PM
Lung Cancer Advances
Jimmy Ruiz, MD, Wake Forest University  

2:15 PM Networking Break/Resource Center  

2:45 PM
New Guidelines on Localized Prostate Cancer Management
Daniel Barocas, MD, MPH, FACS, Vanderbilt University Medical Center  

3:15 PM
Multidisciplinary Management of Bladder Cancer: Improving Guideline-Concordant Care
Chelsea Osterman, MD, Mission Medical Oncology  

4:00 PM
Closing Remarks

5:00 PM
SCOS Oncology Professionals Appreciation Event - 
Osprey Outdoor Terrace
Bring your family and enjoy a Lowcountry boil, s’mores bar, and live music!  

This event is exclusive to all members on the multidisciplinary care team and does not apply to SCOS Corporate Members or those employed by a pharmaceutical, device manufacturer, consulting, or technology company.  

Disclosure Information

Boston University School of Medicine asks all individuals involved in the development and presentation of Accredited Continuing Education activities to disclose all financial relationships with ineligible companies. This information is disclosed to all activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to mitigate all relevant financial relationships with ineligible companies. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.

In accordance with the Standards for Integrity and Independence in Accredited Continuing Education, all relevant financial relationships with ineligible companies that faculty, planners, authors and anyone who may be in control of content have been mitigated.

Accreditation Statement for Joint Conference

Credit Designation for Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Boston University School of Medicine and the South Carolina Oncology Society.

Boston University School of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit Designation for Nurses

Boston University School of Medicine Continuing Nursing Education is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity has been provided by Boston University School of Medicine Continuing Nursing Education and jointly provided by the South Carolina Oncology Society.

Contact Hours: 6.25, of which 4.0 are pharmacology credit worthy.

Learning Objectives

At the end of this educational activity, participants should be able to:

  1. Summarize recent advances in diagnosing and treating a variety of cancers, including breast, lung, and hematologic cancers. 
  2. Describe the role of biomarker testing for diagnosing and treating some common cancers.  
  3. Use new knowledge about immunotherapy to inform decisions related to the treatment of some cancers.  
  4. Discuss the need for more equity in clinical research and cancer care.  

Planners/Speakers

Name of Faculty or Presenter/Planner Reported Financial Relationship
   

Daniel Barocas, MD, MPH, FACS

Daniel Barocas, MD, MPH, FACS, is a consultant for Ambu, Lantheus, Pacific Edge, and Optum Health. He receives grant research support from NCI, Movember Foundation, and EDRN. He does not plan to discuss unlabeled/investigational uses of a product. 

James Davis, PharmD, BCOP

No relevant financial relationships and does not plan to discuss unlabeled/investigational use of a product.

Regina Gibson-Burtnick, BBA, CAE 

No relevant financial relationships.

Asutosh Gor, MD

No relevant financial relationships.

Hamza Hashmi, MD

Hamza Hashmi, MD, is a consultant for BMS and is a consultant and speaker for Sanofi and Karyopharm. He does not plan to discuss unlabeled/investigational uses of a product.

Lynette Henshaw, PharmD, CME Reviewer

No relevant financial relationships.

Brian Hess, MD

Brian Hess, MD, is a consultant for ADC Therapeutics and a speaker for BMS. He does not plan to discuss unlabeled/investigational uses of a product. 

Christy Levine

No relevant financial relationships. 

Richard L. Martin III, MD, MPH

No relevant financial relationships.

Sandra Megally

No relevant financial relationships.

Naomi Moeller, Boston University School of Medicine CME/CNE Office

No relevant financial relationships.

Reid Michael Ness

Reid Michael Ness receives grant research support from Guardant Health, Inc. He does not plan to discuss unlabeled/investigational uses of a product. 

Nitin Ohri, MD, MS

Nitin Ohri, MD, MS, is a consultant for Genentech, receives grant research support from Celldex and is a consultant and receives grant research support from Merck and AstraZeneca. He does not plan to discuss unlabeled/investigational uses of a product. 

Chelsea Osterman, MD

Chelsea Osterman, MD, is a consultant for Pfizer/Myovant. She does not plan to discuss unlabeled/investigational uses of a product. 

Jasmine Patel, PharmD, CME Reviewer

Jasmine Patel, PharmD, is a speaker for AbbVie and was on the Myovant Ad Board. 

Jimmy Ruiz, MD 

Jimmy Ruiz, MD, has no relevant financial relationships and does not plan to discuss unlabeled/investigational uses of a product. 


 

Gene Saylors, MD

No relevant financial relationships.

Julia Saylors, MD

No relevant financial relationships.

Amy Smith, CNE Course Advisor

No relevant financial relationships.

Antoinette Tan, MD, MHS

Antoinette Tan, MD, MHS, receives grant research support from Merck, Pfizer and Daiichi Sankyo and is a consultant for AstraZeneca, Genentech/Roche, Novartis, and Immunomedics. She does plan to discuss unlabeled/investigational uses of a product. 

Emily Touloukian, DO

No relevant financial relationships.

Carmela A. Townsend, DNP, MS, MBA, RN, Lead Nurse Planner, Boston University School of Medicine CME/CNE Office

No relevant financial relationships.

 

How to Claim Your CME and CNE Certificate

To earn credit, you must stay for the entire program. After the conference, participants will receive an email with instructions on how to claim credit.

Disclaimer

These materials and all other materials provided in conjunction with continuing medical education activities are intended solely for purposes of supplementing continuing medical education programs for qualified health care professionals. Anyone using the materials assumes full responsibility and all risk for their appropriate use. Trustees of Boston University makes no warranties or representations whatsoever regarding the accuracy, completeness, currentness, noninfringement, merchantability or fitness for a particular purpose of the materials. In no event will trustees of Boston University be liable to anyone for any decision made or action taken in reliance on the materials. In no event should the information in the materials be used as a substitute for professional care. In no event should information in the materials regarding laws, regulations, or legal liability be considered legal advice or used as a substitute for consulting with an attorney. 


1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
scosonline.com
Email Us